openPR Logo
Press release

Restless Legs Syndrome - Pipeline Review, 2017

09-27-2017 07:38 PM CET | Health & Medicine

Press release from: ReportsWeb

Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome - Pipeline Review, H1 2017, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape.

Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder of the part of the nervous system that affects the legs and causes an urge to move them. Symptoms include itching, pain, a creepy-crawly feeling and cramping in the calf’s or legs. Predisposing factor includes age. Treatment includes muscle relaxants, sleep medications and narcotic medications.

Report Highlights

Publisher's Pharmaceutical and Healthcare latest pipeline guide Restless Legs Syndrome - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Restless Legs Syndrome (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Request Sample Report@ http://www.reportsweb.com/inquiry&RW0001689373/sample

The Restless Legs Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Restless Legs Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Preclinical stages are 1, 1, 3, 1 and 1 respectively.

Restless Legs Syndrome (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Inquiry for Buying@ http://www.reportsweb.com/inquiry&RW0001689373/buying

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

List of Tables

Number of Products under Development for Restless Legs Syndrome, H1 2017
Number of Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Restless Legs Syndrome - Pipeline by Galenica Ltd, H1 2017
Restless Legs Syndrome - Pipeline by Hisamitsu Pharmaceutical Co Inc, H1 2017
Restless Legs Syndrome - Pipeline by Merz Pharma GmbH & Co KgaA, H1 2017
Restless Legs Syndrome - Pipeline by Mundipharma International Ltd, H1 2017
Restless Legs Syndrome - Pipeline by Omeros Corp, H1 2017
Restless Legs Syndrome - Pipeline by Serina Therapeutics Inc, H1 2017
Restless Legs Syndrome - Dormant Projects, H1 2017
Restless Legs Syndrome - Discontinued Products, H1 2017

Find More Information@ http://www.reportsweb.com/restless-legs-syndrome-pipeline-review-h1-2017

List of Figures

Number of Products under Development for Restless Legs Syndrome, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Targets, H1 2017
Number of Products by Stage and Targets, H1 2017
Number of Products by Mechanism of Actions, H1 2017
Number of Products by Stage and Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017

About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Restless Legs Syndrome - Pipeline Review, 2017 here

News-ID: 744362 • Views: 249

More Releases from ReportsWeb

North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT G …
The "Global North America Smart Airport Market: 2020" Industry Report is a professional and in-depth study on the current state of the North America Smart Airport Market by PMR. The North America Smart Airport market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2026. The company profiles of all the key players and brands that are dominating the market have been given in this
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles Summary "Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy. The report provides in depth analysis on global renewable power market and

All 5 Releases


More Releases for Restless

Restless Legs Syndrome Treatment Market Opportunities and Forecast Upto 2024
Global Restless Legs Syndrome Treatment Market: Overview Restless legs syndrome, also called Willis-Ekbom disease, is a neurological disorder. It triggers an urge in patients to move their legs. Because the syndrome usually occurs during sleep, it is also considered a type of sleep disorder. People suffering from restless legs syndrome often feel an overwhelming desire to rigorously move their legs, the intensity and frequency of which leads to unpleasant pain in
Restless Legs Syndrome Treatment Market Trends and Forecast Upto 2024
Global Restless Legs Syndrome Treatment Market: Overview Restless legs syndrome, also called Willis-Ekbom disease, is a neurological disorder. It triggers an urge in patients to move their legs. Because the syndrome usually occurs during sleep, it is also considered a type of sleep disorder. People suffering from restless legs syndrome often feel an overwhelming desire to rigorously move their legs, the intensity and frequency of which leads to unpleasant pain in
Restless Legs Syndrome - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Restless Legs Syndrome - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome - Pipeline Review, H1 2017, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder
Global Restless Legs Syndrome Consumption 2016 Market Research Report
ReportBazzar has announced a new report titled "Global Restless Legs Syndrome Consumption 2016 Market Research Report" To their offerings Browse Report Summary with TOC: http://www.reportbazzar.com/product/global-restless-legs-syndrome-consumption-2016-market-research-report/ The Global Restless Legs Syndrome Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Restless Legs Syndrome market. First, the report provides a basic overview of the Restless Legs Syndrome industry including definitions, classifications, applications and industry chain structure. And
Studies Show Natural Remedies for Restless Leg Syndrome and Insomnia
Restless Leg Syndrome as a disruptive condition that affects the nervous system and up to 10% of the U.S. population have some form of it. It results in an irresistible urge to move the legs (and sometimes the arms), often accompanied by unpleasant sensations in the legs such as creeping, crawling, tingling, pulling or pain. Because RLS most often occurs in the evening, it can disrupt sleep, contribute
Restless Leg Syndrome and Insomnia Linked to Magnesium Deficiency
Restless leg syndrome (RLS) is a form of insomnia characterized by an overwhelming urge to move the legs when they are at rest, especially during sleep. RLS affects about 10% of the people in the U.S. It runs in families and may have a genetic component. Recent research has found that people with restless leg syndrome are deficient in the mineral magnesium. According to the National Sleep Foundation, almost